APA (7th ed.) Citation

V, L., CS, S., & A, R. (2021). Pharmacology-based ranking of anti-cancer drugs to guide clinical development of cancer immunotherapy combinations. Journal of experimental & clinical cancer research : CR, 40(1), 311. https://doi.org/10.1186/s13046-021-02111-5

Chicago Style (17th ed.) Citation

V, Lemaire, Shemesh CS, and Rotte A. "Pharmacology-based Ranking of Anti-cancer Drugs to Guide Clinical Development of Cancer Immunotherapy Combinations." Journal of Experimental & Clinical Cancer Research : CR 40, no. 1 (2021): 311. https://doi.org/10.1186/s13046-021-02111-5.

MLA (9th ed.) Citation

V, Lemaire, et al. "Pharmacology-based Ranking of Anti-cancer Drugs to Guide Clinical Development of Cancer Immunotherapy Combinations." Journal of Experimental & Clinical Cancer Research : CR, vol. 40, no. 1, 2021, p. 311, https://doi.org/10.1186/s13046-021-02111-5.